Evaxion Biotech A/S (EVAX) Financials
EVAX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | -75.1 million | 14.7 million |
| 2023-06-30 | 16.8 million | 14.2 million |
| 2023-03-31 | -58.9 million | 13.7 million |
| 2022-12-31 | -58.9 million | 13.7 million |
EVAX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | ? | ? |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 17.9 million | 942 |
| 2022-12-31 | ? | ? |
EVAX Net Income
No data available :(
EVAX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 2.6 million | - | - |
| 2023-06-30 | 7.1 million | - | 2.3 million |
| 2023-03-31 | 13.2 million | - | - |
| 2022-12-31 | 13.2 million | - | 2.3 million |
EVAX Shares Outstanding
EVAX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 2.8 million | 2.9 million | - |
| 2023-06-30 | - | 2.9 million | 2.7 million | - |
| 2023-03-31 | 440000 | 4.1 million | 2.5 million | - |
| 2022-12-31 | - | 4.1 million | 2.5 million | - |
EVAX Cost of Revenue
No data available :(
EVAX
Price: $3.95
52 week price:
Earnings Per Share: -8.10 USD
P/E Ratio: -0.42
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 302177
Market Capitalization: 21.3 million